HOME >> BIOLOGY >> NEWS
Open Access journals proven to compete on quality

LONDON and PHILADELPHIA: Open Access journals published by BioMed Central have received impact factors that compare well with equivalent subscription titles, it was announced today. The high impact factors, all for journals that are just a few years old, prove that Open Access to research literature achieves impact fast and makes quality articles much more widely visible.

Arthritis Research & Therapy jumped from 3.44 to 5.03, propelling it to rank second in the rheumatology field in only its 6th year of publication. Breast Cancer Research also increased its impact factor moving from 2.81 to 2.93, placing it on even footing with its direct competitor, Breast Cancer Research & Treatment, which was established more than 20 years ago. Critical Care moved up to 6th in its field, and now has an impact factor of 1.9.

Four journals published by BioMed Central received their first impact factors this year. Respiratory Research (5.53) comes in from nowhere to immediately take second place in the respiratory field. Current Controlled Trials in Cardiovascular Medicine has an impact factor of 3.12. BMC Cell Biology (2.61) and BMC Health Services Research (0.67) also entered well. BioMed Central saw its impact factors go up across the board. BMC Cancer now has an impact factor of 1.7, while BMC Infectious Diseases (1.25) and BMC Public Health (0.93) also saw increases in their impact factors from the 2002 Journal Citation Report.

The impact factors, which are calculated by ISI, look at articles published in the journals in the period 2001-2002. To BioMed Central, the excellent performance of its titles answers spurious accusations of low quality of Open Access journals by some traditional subscriptions publishers.

Jan Velterop, BioMed Central's Publisher, said:

"It is becoming ever clearer that BioMed Central's Open Access journals, once beyond their early infancy, are recognised as superior to their subscription-based competitors w
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
25-Jun-2004


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. Access to DNA secrets yields better understanding of genes, possible tool for disease diagnosis
3. OUP launch a new Open Access Journal on Complementary and Alternative Medicine
4. BioMed Central explodes Open Access myths
5. Open Access Initiative from Oxford Journals
6. Access to healthy foods limited in poor neighborhoods
7. Sick Kids Improves Access To Global Genome Database
8. Select research highlights from current AACR journals
9. Tips from the journals of the American Society for Microbiology
10. Tips from the journals of the American Society for Microbiology
11. American Society of Plant Biologists offers developing nations free access to science journals

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... , ... Lajollacooks4u is delighted to announce it has been named as one ... given only to businesses that have achieved consistently outstanding traveler reviews on TripAdvisor, as ... To qualify for the Certificate of Excellence –- an award that only 10 percent ...
(Date:5/31/2019)... ... May 30, 2019 , ... Researchers from Ambry Genetics ... significant differences in the prevalence of hereditary genetic mutations, also called germline mutations, ... women. Results will be presented at the 2019 American Society of Clinical Oncology ...
(Date:5/26/2019)... ... ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat spinal muscular atrophy ... by the Food and Drug Administration today. , The treatment is now ... United States and the second-ever approved treatment for SMA. , FDA granted priority review ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... IND is the first of several planned clinical trials which will enable qualified PSC-enrolled ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Clinic, a national leader in opioid treatment, announced today they are partnering to ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic to ...
(Date:5/31/2019)... City, California (PRWEB) , ... ... ... allowance of our patent applications from the USPTO providing proprietary interest to ... AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights ...
(Date:5/21/2019)... ABABA, Ethiopia (PRWEB) , ... May 21, 2019 ... ... für Brauerei in Berlin (VLB) today officially opened the inaugural Africa Brewing Conference ... brewing and malting industry in Africa. The event, which is supported through a ...
Breaking Biology Technology:
Cached News: